Anticoagulation group(Apixaban group) Clinical Trials
2 recruitingDrug
Phase 42
Showing 1–2 of 2 trials
Recruiting
Phase 4
The Efficacy and Safety of Non-vItamiN K antaGonist oraL Anticoagulants for intermEdiate Stroke Risk in Patients With Atrial Fibrillation (SINGLE-AF)
Atrial Fibrillation Patients With Intermediate Stroke Risk
Yonsei University1,800 enrolled1 locationNCT04437654
Recruiting
Phase 4
AnticoaguLation ONE Year After Ablation of Atrial Fibrillation in Patients With Atrial Fibrillation (ALONE AF Study)
Atrial Fibrillation Patients With Moderate or High Stroke Risk Who Had Undergone Catheter Ablation of Atrial Fibrillation
Yonsei University840 enrolled1 locationNCT04432220